Carney: 'If the United States does not want to lead, Canada will'
Trump said on Wednesday that the U.S. will impose reciprocal tariffs of 10% on all imported goods, with higher reciprocal rates for some nations that will be half of the rate they charge on U.S. exports. The 10% tariffs will go into effect on April 5, while the higher "half" tariffs will begin on April 9.
The U.S. administration also confirmed previously announced 25% tariffs on imported vehicles and auto parts. Additionally, Trump implemented a 25% tariff on goods from Mexico and Canada that are not compliant with the USMCA deal. There is already a 25% tariff on steel and aluminum in place.
In answering, Carney said, "We are responding today with carefully calibrated and targeted counter-tariffs." He confirmed that Trump has been aware of this after their call last week.
He then announced that Canada will match the U.S.' approach with 25% tariffs on all vehicles imported from the U.S. that are not in compliance with the USMCA deal. Carney went on to verify that auto parts will not be affected by these tariffs, and that no tariffs would affect vehicles or vehicle content from Mexico.
Carney alleged that total funds raised from Canada's tariffs could reach CAD$8 billion, and all funds will go to the autoworkers and companies affected. This excludes a CAD$2 billion fund announced last week to bolster Canada's auto sector, which would be applied if Carney and the Liberal Party win the upcoming April 28 election.
The Prime Minister confirmed that the tariffs will remain in effect, though they are imposed reluctantly. He underscored that goods chosen are meant to have maximum impact on the U.S. and minimal impact on Canada.
"As President Trump and I agreed last week, he and the Prime Minister of Canada will sit down immediately following the election to find areas of common ground and agreement in a new economic and security partnership," he said regarding the future of U.S. and Canada's trade relations.
The U.S.' exemption of Mexico and Canada from those reciprocal tariffs, as well as the USMCA goods exemption, have been seen by many to be a positive break for the two countries. Carney acknowledged this, calling the sparing of Canada "progress."
However, Carney pointed out that tariffs will still impose serious problems for Canadian workers and businesses, calling them "unjustified, unwarranted, and misguided." He addressed the already-yielded consequences, pointing to a Windsor assembly plant that told UNIFOR union workers that it would be shutting down for at least the next two weeks, costing some 3,600 employees work.
In his repudiation of the U.S.' trade policy, Carney stated that there was a 97% drop in fentanyl seizures on the U.S.-Canada border in January compared to December. Fentanyl and other drug-trafficking have been cited by Trump as one of his chief objections with Canada.
Furthermore, Carney looked to the U.S. Senate to bolster his claims, as U.S. Senators Chuck Grassley and Maria Cantwell introduced a bill to curtail the President's authority to impose tariffs unilaterally.
Carney reiterated previous statements criticizing the U.S. for violating the USMCA agreement with its tariffs, saying that Canada is fighting in courts, filing disputes, and has approached the World Trade Organization in efforts to halt the tariffs.
The Prime Minister spoke of the previous relationship between the U.S. and Canada in automotive trade, citing the Canada-United States Auto Pact, an agreement that ran from 1965 to 2001. The pact removed duties on most automotive parts traded between the two countries. Carney expressed that the same trade symbolized under the pact is "over," unless a new approach is found.
Continuing, Carney conceded that despite the U.S. not targeting Canada in yesterday's announcements, the tariffs will "rupture the global economy and adversely affect global economic growth." He stated that the world's trade, previously anchored under the U.S., is also "over," saying, "The 80-year period where the United States embraced the mantle of global economic leadership is over."
He further emphasized the importance of Canada's individual growth through expanding trade elsewhere, building the economy, and protecting their sovereignty. Carney contended that Canada is ready to bear a leadership role in the world, saying, "If the United States does not want to lead, Canada will."
To conclude, the campaigning Prime Minister implored Canadians to "draw strength" from each other, calling for economic unification across the 13 Canadian provinces.
Regarding the future of the U.S., Carney expects Trump to change his course, pointing to the pain that this potential trade war may cause on Americans and saying, "Until that pain becomes impossible to ignore, I do not believe they will change direction," but, "They should eventually change course."
Related articles
Roth/MKM upgrades Constellation Brands A to 'buy' with a price target of $270.00
RBC Capital maintains Travis Perkins at 'outperform' with a price target of GBP12.50
RBC Capital maintains Nestle at 'underperform' with a price target of CHF98.00
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
22 minutes ago
- The Hill
Trump's new model to support Ukraine is a win-win
From the start, Ukraine's defense against Russia's full-scale invasion has been underpinned by a robust commitment from its Western partners. The Biden administration's pledge to support Ukraine 'as long as it takes' promised a sustained flow of military and financial aid directly from Washington. This 'direct donor' model was key to Ukraine's initial resilience, providing essential weaponry from U.S. stockpiles. Biden's approach primarily involved direct transfers from U.S. weapons inventories, prioritizing speed and ensuring that Ukraine received vital equipment quickly to counter Russian aggression. The American government provided extensive amounts of equipment, from air-defense missiles to artillery rounds and armored vehicles, directly to Kyiv. Now, under President Trump, the paradigm is shifting. The U.S. is transitioning from a direct donor to a 'strategic supplier,' where European allies purchase American weapons for Ukraine at their own expense. While this reorientation marks a significant change, it is far from the worst-case scenario for Ukraine. Instead, it represents a pragmatic and potentially more sustainable evolution of transatlantic burden-sharing, securing critical capabilities for Ukraine while invigorating the U.S. defense industrial base and recalibrating the nature of allied support. Support is still 'as long as it takes' but also 'at the others' expense.' This marks a departure from the traditional post-World War II donor-recipient model, particularly within the NATO alliance, towards a more transactional 'America First' approach. Future U.S. engagement in global security will likely be contingent upon tangible economic benefits and direct cost-sharing from allies. Such a shift could lead to a more predictable, albeit less altruistic, framework for security cooperation, where allies are compelled to demonstrate their commitment through direct financial contributions. This policy reorientation accelerates European strategic autonomy. While the immediate effect is Europe paying for U.S. weapons, the long-term implication is a forced impetus for greater European defense integration and self-sufficiency. European nations have already been increasing their defense spending and proactively planning for a future with less guaranteed U.S. aid. This new model, by making U.S. weapons available for purchase, encourages Europe to develop its own robust procurement mechanisms and potentially expand its own defense industrial base. Ukraine's most pressing and enduring need remains robust air defense against Russia's escalating missile and drone attacks. The U.S.-made Patriot air-defense system is critical, as it is one of the few systems capable of intercepting high-speed ballistic missiles. These systems are vital for protecting civilian infrastructure and population centers, which have been subjected to relentless Russian bombardment. A critical strategic reality for Ukraine is that not all American weapons are equally replaceable by European alternatives. While Europe is ramping up its own artillery production, the Patriot system's unique counter-ballistic missile capability makes it a requirement that only the U.S. can provide at scale. Europe, at the same time, has demonstrated a clear willingness and increasing capacity to shoulder a greater share of the burden. The European Union has already provided €165 billion in financial assistance and has launched an €800 billion Defense Readiness Plan. Frozen Russian sovereign assets may be used to finance what Ukraine needs. The shift to a foreign military sales model is explicitly intended to invigorate the U.S. defense industrial base. By integrating 'exportability features' into defense systems during the design phase, the U.S. seeks to advance its competitiveness abroad and potentially lower unit costs for both America and its allies. While the foreign military sales process has historically been slow and plagued by delivery backlogs, the new model offers a potential solution. Consistent, large-scale orders from European allies could provide the long-term contract certainty that the U.S. defense industry requires to invest significantly in surge capacity and overcome challenges. This transforms what was previously a 'drain' on American stockpiles, requiring replenishment at taxpayer expense, into a sustained stimulus for U.S. manufacturing, aligning with 'America First' economic principles. This shift is not merely about burden-sharing; it is about recapitalizing and modernizing the U.S. defense industrial base. While immediate fixes for current shortages remain challenging, this strategic reorientation creates a more sustainable industrial ecosystem. Trump's recent rhetoric marks a notable change from his earlier stance, which often appeared conciliatory toward Vladimir Putin. He has recognized that Russia, not Ukraine, is the core problem in negotiations, even threatening tariffs and sanctions on Russia and its trading partners if a peace deal is not reached within 50 days. The reality that Putin is not amenable to a quick 'deal' is now clear. There is now a crucial political opening for continued support to Ukraine, even if the funding mechanism changes. The narrative that Trump desires Ukraine's fall has been refuted. Instead, Trump is committed to ending the war on terms that align with his administration's interests. This represents a significant psychological advantage for Ukraine, as it lessens the fear of a complete U.S. abandonment.
The Hill
22 minutes ago
- The Hill
Columbia to pay $221M to restore funding cut by Trump administration
Columbia University said Wednesday it has agreed to pay the Trump administration $221 million to restore federal funding that was stripped following a probe into antisemitism on the campus. The school, according to the settlement, will pay a $200 million settlement to the federal government over a three-year period and $21 million to the U.S. Equal Employment Opportunity Commission (EEOC). 'This agreement marks an important step forward after a period of sustained federal scrutiny and institutional uncertainty,' Acting University President Claire Shipman said in a statement. 'The settlement was carefully crafted to protect the values that define us and allow our essential research partnership with the federal government to get back on track,' she added. The interim president said the Trump administration deal will allow the school to maintain its academic independence after losing $400 million in grant funding earlier this year. In June, a judge dismissed a lawsuit led by Columbia's faculty, ruling that only the school had grounds to sue the government for revoking its funds. 'Columbia's longstanding research partnership with the federal government is vital to advancing our nation's progress in key areas of science, technology, and medicine,' Board of Trustees Co-Chairs David Greenwald and Jeh Johnson said in a statement on the matter. 'We are proud of the role we play in advancing this public service and preparing the next generations of students to meet complex challenges around the world,' they added. President Trump announced the agreement on Tuesday night in a Truth Social post celebrating the win for his administration. 'It's a great honor to have been involved, and I want to thank and congratulate Secretary Linda McMahon, and all those who worked with us on this important deal,' he wrote. 'I also want to thank and commend Columbia University for agreeing to do what is right. I look forward to watching them have a great future in our Country, maybe greater than ever before!' He warned earlier in the post that other schools could face similar measures to motivate the erasure of diversity, equity and inclusion (DEI) initiatives, which the administration has deemed discriminatory. 'Columbia has also committed to ending their ridiculous DEI policies, admitting students based ONLY on MERIT, and protecting the Civil Liberties of their students on campus,' he wrote in the post. 'Numerous other Higher Education Institutions that have hurt so many, and been so unfair and unjust, and have wrongly spent federal money, much of it from our government, are upcoming,' the president added.
Business Wire
22 minutes ago
- Business Wire
Pramana Receives Health Canada Authorization for Digital Pathology Scanners
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Pramana, an AI-enabled health tech company modernizing the pathology sector, today announced it has received Health Canada Medical Device Licenses for its flagship digital pathology scanners, the SpectralM and SpectralHT Cubiq systems. The approval authorizes Pramana to import, market, and sell its devices in Canada, expanding access to its advanced imaging and workflow solutions. Health Canada authorization is required to commercialize Class II medical devices and affirms the product's safety, effectiveness, and quality. The approval opens the door for Pramana to support Canadian hospitals, pathology labs, and research institutions, helping modernize diagnostic workflows with scalable, AI-powered digital pathology tools. This recognition marks a critical step in Pramana's international expansion, building on its growing regulatory footprint. 'Receiving Health Canada authorization is a major milestone in our commercialization strategy,' said Prasanth Perugupalli, Chief Product Officer at Pramana. 'It reflects the strength of our product development, quality, and regulatory readiness, and it opens the door to expanding access to our technology in a market known for strong clinical and academic institutions.' Pramana's scanners are designed to digitize a wide range of pathology slides, producing high-resolution whole-slide images with automated quality control and AI-powered decision support. The platform supports both FFPE tissue and Liquid Based Cytology (LBC) samples prepared using methods such as the ThinPrep® Pap test (Hologic) and BD SurePath™ (Becton Dickinson). Unlike most digital pathology systems focused solely on anatomic pathology, Pramana expands digital workflows to include hematopathology, microbiology, and cytology, delivering flexibility across all major slide types. 'Our research at the University of Toronto highlights the need for adaptable platforms that can manage these technical demands while still supporting routine histology and cytology workflows,' said Dr. Carlo Hojilla, Consultant Pathologist at the University of Toronto. 'Pramana's technology meets that standard, and its Health Canada authorization reflects both its clinical utility and the rigorous quality required for widespread adoption.' Prior to receiving Health Canada authorization, Pramana secured Medical Device Single Audit Program (MDSAP) certification, a requirement that validated its quality management system and streamlined regulatory access in Canada, the United States, Brazil, Australia, and Japan, highlighting Pramana's commitment to modernizing digital pathology worldwide. To discover how Pramana's whole-slide imaging solution can help healthcare organizations across Canada, visit About Pramana, Inc. Pramana is a health tech company transforming digital pathology with AI-powered imaging solutions that support seamless adoption across labs, health systems, and medical centers. Pramana's Spectral scanners deliver industry-leading image quality and unprecedented accuracy. Built-in AI algorithms and automated quality control streamline workflows, increase efficiency, and capture previously undetectable tissue features, empowering pathologists with the tools needed to improve clinical diagnostics and research. The company is headquartered in Cambridge, Mass. For more information, visit
